HypercalcemiaÑD®ÑD®TEXtREAd °Bo€ÀBo€ Bo€úBo€äBo€$õBo€-ÝBo€6“Bo€?½Bo€H Bo€ Q Bo€ [;Bo€ ¤’ Hypercalcemia €**DifferentialÄiagnosisïf |Primaryè‚Aparathyroidism Sporadic (adenoma,Llasi€horãarci€Ù)€Familƒ©(isolated,ãystic,ÍENÉ,ÉIHCancerƒPƒ—èormone-reÒðrotein„8Ectop„0€duction†a1,25-dihydroxyvitƒènÄ…¸Oth‚ðfa¸rs´‚ˆe‚;ally (cytokines,çrowth…†ALy…˜â„píetas€es D†°rde‚ ŠXƒ…xog‰us€·ôoxicitƒX„Þ, …OH-€H…ê€Y‰¹End‚‡y|:×ilŠÀmsóyn‡xme··ˆÏƒ<Ž GranulØt„ùŽÀe†c SØXâ€Tub’`h€His‹È`m&Coccð¹mycÞLepsy‚º‹òƒLymph‘° Non’÷ŒX‡cr‹ø„‘Ф T“á‰Â„¤Pheoch‡€oym— Ad–È–¸insuff‹encƒÁVasoˆive€Øte“ 1peptide’æ’ingôum•ð Isletãelh”°reaÙ€òMe—ð€on…iaz‚ydiure–°ŠALithiu™qEstrA’˜a›à„ €}„oster—€é•A›Milk-alkaliŽç†p–tA†i’I„"‡ùlu—0ƒxexces‰"aŸQerŸXnutri˜úŠjeophy‘Àƒ¢˜à€~žÐ8-chloro-cyclŸAMP„q‡ássociœRw‡¡£VœÀc˜¨òe¡t˜àImmobŸèz…S(¢¡áoutÐaget'”¤i›¡°¡®¤ o¦YŠè£˜ƒ‡¦ÒAcute‰Ù ‰n¤ GG H޹‚c¨Çƒjenign£À•(Jansen„hžé‰ ˜ l‚¸ošÙdys¦ó RŠÐ bo‰cŠòs:…Z–Øspha ø¨YpªLoxaš ,Çauc¤@‡§¬ù90%¬A¤ Š‹8ƒ caus§ˆb¬?¬?m (‰øp”°®€¤èˆm‘p†d(išÀ€ä. ¯òRegu«à©4Ser”èCŠº®˜€L: 99„Jtot± b‡¸ (1000ç)®˜k±˜extra˜é‚r,¨uŒto ‡åeóalø­8« ókešpù¬´a…Éte). 1%‚‰œà‚Žz‡Úf²Q€µfun¯*” xs¹–(g;…ls†’…/ “0.ƒ†—†‘†LƒèAv™g’dulŸp‡ ng¡I²x¸ð1ç/µx—b10-2Hab¯€bed…ðGen›ly,°n›ñ e < 3‰ mДÚw¬Ðn€¨25€¬µø–hne.Á…*4û†‹D·e‹ (‘1‹0albŸq„¨hicœa…02Œþbi”€¦Ps‹sÛn¹ø¶Úon·…ù­Xupied],8max» èglobu ¸s)Š˜°unƒ¼5”èºèiz½Á1•Pcomplex  ¶h½he/æ‘W†š8iolog» ¬c‡ÀŠèªº¡h¾h†œ¾‹‰LïŒØ …ëVœÑas« “i• ‡¦y@8‹ŠL’ Ve›r¨ŒÁƒ=™onoclo° ŠËs¥p„O‚÷‚÷‘D¶è§„UˆŒ˜µ­úž­¨JdeNt (˜he…±Ž†#)ªnoåffect †Ï•Ù®P¹µŒ (PTH, 84® аid²øin¯8j± »xs…øa 115á.a.’™·´¤é½-‚`œQ‚˜š(– —Ür¡“¤‡‡¡›level;ìow®yf¥Ð¹ù€÷ads ‘‹÷‚ÿ¤Žùƒpªès;k°€¿x¯u²z‚?‚?…0mRNA‹‹‘2dayƒb¾Xthˆ:•gl¨Ãss‡’W³1µ8žPp¾A‘F†7m²º¦ž¥`I¦{kidne’Ñt?¨ö ¼±´©•רß‚‘t¾Pdirè—G¾ø¤¶Q„n£±…b°‘¥m®zŸP«´0¦`›X®ò25-«Tvit¿!Ä3 (º*dœp)­a1,0diGG»itrI­Magn’P¯Ërequ…p´¨o¿à¬ù‘±›H½ê˜­"–Rar¾àôissueŒ“¥aa¥lf-lif¿z< 4 ¦p¾8¸ue²9rap—`c’(r¼Ð—phe·Qc >¾ó)§Ýg«ú§Až¸ger-½ˆš‰Ð£JÃ-›Ð©h¿àf¯X­(´¸©Ã¾9¨ª‚¢©ƒŠ®¸¹V‰Å (e¯Ø©D2—ID3)íustâ‹¥™¬©ƒƒmet³Àl«â(Œ?»Ì¸„l¨¹¸1a€ÿ€ÿ”±¥xi§ñŽÙol‰»u­«»Xha†ðbªÜ¢ºx¾’âµê½Ð‘H©Éo‡pp²pnŒh§¨n”3’…“ç©9(duod‹’˜§˜§¿8”¯½ª§·†#šOšO˜˜ WºÁ£Ñ¤`sŒè,¾†¯Æœ—œ—­€obilizŠãfro·è¨èš»als£ñhibi¦ç¾¹v®Paæeedback¦ op‡X­–£½â¢)¬r $e•’É«°7-de›rchol°er‹è(½Ø›ç)¾i¹8ns™˜mª‹n®@nzym–ʹèto¸â‘K¿0¬èxõl»pvºšÐligh²èwPleng¼`290-3¯Pnm,ÕVB). BodyôemperatureæavorsãonversionïfðrevitaminÄ3ôoôheìipid-soluble  (cholecalciferol),÷hichésòeleasedén‚£èp€0·€tebra‡Ø?ån… c½(‚_ƒÓde­(ty¨Nµàpe›Â ®PŠ.s–Íd´€Šä¾ÝChondž‡is/pseudogout˜ÂºCardiov¦ ­Z -D®QTŽ3vºÊ¼è³ñ±‘»°raư um¬p¶3t»€²H(Ÿ`uˆÁŠoci»ÂˆQŠXyŽr˜saf¬H—Xccessfu½y·®˜rg•ºyE‰=§ˆˆ¸ivˆØ´Ñdigi¯Ðºð•Éadyarrh–½•{first-degreø›ètâlo­Ð¼u-¼Pp’€·è°á¿È²¸i‹ðce®yˆv¶I,íy¨ð‰ˆ½°¿Ñ” ¼X­ˆ‚˜š(¨×§LVH¶ØÒ½š­"ƒ$¸-level…茉ŒE¨¯¨¯«Ÿ¹b‚¶¸n«or§ð³(§P”ðŒ¨ µ0‰@a›Àľ8x«qt¬Pˆr³G³G´§¹c®£d›¨ge¯a½Ã®pro™É–È50-70—ñAbnor±IdЍ– àccu¬©á¨a¯Úmaj­@˜²°µAŒ»(‹Yƒ@‹Eum),ëidne¨iki¾`jo¢Ø¶Èmuscle (³8º˜¿p¿ùº ·pµ²,§biºhoºØ•¨ct,³ò¡iex…”!¾Ø½Ñ¢ ¢Ðn€p(bµk¥xµ(¼Q)¨ÑC»¢°lax¾€¾˜acu¶Às°¯8cíeò¹'¾Ü‘iµ€which®Yul©:·ÅisˆH±H®Øur€·‘laques,ándîecroticõlcers÷hichïftenâecomeénfected. Calciphylaxis €rare (< 200ãase€eporp),ðrepitaèâyìocalôissueôrauma,‚ðcludingƒ@jƒ@ion„Ühasáðoor‚Pognosis„ ItƒÉmost „ømonlyóe…xinånd-stage„8nƒ`dise„°,âutálso)s†©hyper„xcem‡è te‚éPathogeneƒ`‡Èvolv† mo‡0thaƒlev†zÙiumŠ"phosph‡0‡˜ossib„rel‡ºto§PTH ‚els † use‹@Š˜CO3,‚ƒtriol,€é‰Ødnisone. VIII‹øNormochro… ,î€ryéan†8aíay¨ˆvsƒ`Œø‡Zpar†Øyroiˆ m‚ª**H€×€Õ ƒpƒXEpidˆÐology -OccuèaŠ(ny ‹Љ‚ð‡Hunder€Â15‘8M‰ðvalenxn‰èo‡y„€ò40†¸-PeakƒXnc“@‹‘æifth‰¹six€HdecadŽwi€°fem‚:€)‰Ù3.5:1‚I100,0”new”4`U.S. (ùear;„~ƒH‹°1‘q¸„BS•ad˜ prima† ‰—ˆÇ—€associ–r„zexter“9š(†Hr‚)a– šÒl…‘therapy‡ŠŒ/Œ´lasÀ–‚šH–ƒ–IyoungŠ˜p‚€Š˜H`conœˆš€Š ‚¨edšØŒ—(orŒs; ‰Xnoma’àual˜Á†ÕŸY™-oli‚Õ“’ñE›Ø|85%‹øng‹8‚”;ŽÈ%íultip‹ègl š!funª (†—ž¸^„œs); <0.‚Ècarci…1ža„pn•‰ri¡Ø8%Ÿ dŸ mØu¢È˜ø†•&‰ia‘éU‡¤ñ™¸r„£ˆ chief-cell‹'i†maj¢Phist–±§fin£Á:¡1app‘0aôf—H¢p™§ž@¥³‰bœXMod§`ø§ s— »‰Ð0% ¨™asymptŒXªÙ•âmil¬£´ˆ‡øð©˜ma„`erž epžø‘ÚЫ¬cA§[‚ËšAcut›A•¯Ÿ?Ÿ::•‚ðe© o„°ž2high¥ɪÊns ”•—Πˆ"¤[ª"£'£':”6«`oalbumi¥9c¬j­h±ƒžÊtr°¦ƒˆì,ˆÒÈ« «e´ dsª‘± r®Á¢‹time£©§è³èŒƒ±Èsµðndž¨žznµP˜øn¬0­ °~iurœ‰nducµ«aˆãsod¯ydie¨!šh€ƒex„P—ûJ°í¸è°Rge a).§á—ÐMENŽpnd®x¼q­?¬o‡—´[œ—s«a‚0I (¯d (†±·€¸8~25¨s¼yitu¡’¼Ð—PŠ¿Átu¶ð¡Ùuto¸Ð¹©²øn£ ž)–̵@men®Aqóup—Á£¸ ¹a)¶yIIA (medullªCA¹ˆ³z¸¨heµ³µq¤ø„¨O[84ŸÀ¨w, 16š(¦S„ is]„÷„÷,á£À¼h¥@…OºˆRET¹øoto-©y…³iFaœi­h¯/¸¿·î?cysºÑ¹Ç¤È„§s¸¨Neonat¯ø»D±÷»‡œNŠÿrec‰Øiv¶¨hˆ˜zygou·Ñ†‹Æ£—ô-£8¬¡‚¢Ø¡h¯§´ån‹°ge‹hCa >Šíg/dL,ž÷žñì (ls ¾¿ß¿Þ-jaw ”¼:¾ú”ç¸m, ¦(¾ð‹8†pfyŒ9‚ fib–ˆa–ˆre¸áŠA–ðWilms'“s€Ýha»p©)–AA”” (‘¨. 1q24•ð¨;²¿²¼‘p«˜d†Áop­—¥³@·V.Ìab¿H‰Øy¯åŽ9ˆR¬¥:Þâ´™®¸orp¾iŠ †]l±%ŠophosphatªZ(1/3°Š½”)‚YÇÅEŒdŒzrel¿ž¸¦ §_§X:› o®èƒª!­/©»S®.shou²àœ­®9;ήÁs’ÈC©¸rž‰l»pt™ JIRMAío¯X’º„*¦ºpecific)´ê°ÚµÊ­b,»hge˜¸ “½@e™Io·øi èg«©ign‚ùamou¬P¾(” €…”_®q†´»ðg®AId‚°l¥(•‡beärawnḠr¯ week½‰low-±5­(no»‘k,ùogur¦`i¾Ø±±•Éhe½¨¨·ù¦©¼ faŸx¢Ps¾XeºéL‚˜‹„25-OH-D­¹1Œ,¨8eŽe(30%) 1,L¹Urª¼¨µÝ±G‚'l¶Y‚'30-4–XŸ’¸È)»0^ ´p‚CAMP:€2 £à¶Û¬˜s·`g½8ºpkidne–ȬøŸQ¨é´°‚!º+C‘ÀCl/PO4¡30”øµàh‹¡lÓ€ð©à·és¯t™ˆl½ˆ¸óhlor¾acid¨$v½HCO3:‘[o¿j‚7¿„®alkali›xš]¾¨ŸXst±ˆ¿©n:÷it»ð’¿œû¾ e”˜ (reflect©P©b²–˜ti¹@µÒŠ7¯›»hxy°ðƒ©¸yr»@n€tde€á€Ÿ­N-›èop«€id¨h„g„g„g„g† „g„f ¤8Óurg™lÇu‚¸ˆ²y›€£É @i›Y®é¢e–x=61)õndergo•B‚ ®Úadš iz½fŠìž€’²+š­vels,ándáóustainedéncrease€Hìumbar &æemoralîeck (cancellous)âoneäensityâutîoãhang‚ radiusortical‡. There÷€)ɃÀsïfòecurren‚xephrolithiasis. -Ind‚`tionsæor…àrgery (upôo 50%‚p‚s÷illíeet …Y‚èthese): 1.ÓerumƒÈlci€@> 12íg/dl€ð2.Íarkˆ hyper#ria0400:‚ 3.ÁnyïvertíanifeŠX„ñ†IÒparathyroidism (eg.†Ç†Ã)„p4ƒ…lyˆducŒp‰Í‹G‹A(ŠÁŒx‹Å> 2ÓDâelowîlÛz < -2]‚±5.Ò‚mŽÈtin8ãle„¨Ž8ˆøth©oˆ¸réŽXtifiabl(au@(<7Š“nø 6‡€Žè<‹@Š7.ÅpisodŠÒacuteðrimaŒ€‡ç‡ç(ˆg„i‡Û-Cu0‰(eŽŠtho”„Éo’ˆprevi“`“ëmi‘@‹˜ 90%¡B‹¨ìo“iz‹ët€‘0anåxøhЉŒgd‘Ëon’¡Preo ’°ve‚G‚E–99mTc-”øtamibi ‡ging (77%ó˜Ø, 96€xpecŠ c”òa˜èoma™ tec•©),ÍRIÏÊ€¨ultrasouœ€(5‚¯€âCT (42ƒOart†°ograph—è6—¸„G 95„Gƒselƒñ†èv„xœ˜sampl† šPTH (8‚„€)ƒœ¡Š ›{ Ø(do€’de¡‰Ÿtimšàr ¡8b—0ty)‹°cepùž¿Q–rfail™ðŽÿŽÿšx0o”uy™¢`¡Pme—Ès–(¤hš¿‰extend¦fielŽØNs¥p)£PSßsôaken ¡€b•8igh›metab£H¥0œa‰ktissu˜h™pt,¡Ðž*,’7€is“¨v—‰glªh‰Èªwas£0 –mo”ØsœÐž¸from†j Ÿd¬ …!äªQ1.5-3 —Àr•Ðf’m˜sà–»oŸ8—`¢PžXguish–§‚hƒ£”«(E š©ughé˜ªŠ„Âac«H›Á¥'°–㑱Š7an¡Èg­n£@¯0n›t˜)±X1“€ —s›¹¥ècbˆ¸k”h¤è³P™°¢à‘a—ip£@foci¯±upŒÁ³É€ÚŠzul´©¸´™¯éAŠ`¯ƒµØ®Èf‰Xž¯ˆ m¶X…¦]ed±ª¤ðnœn¡ð¢¸¸ŽªatÛ¢©r·Pv¸8¸¹¨›Ž²sâiops‚h¶intr¯s¬ );óo—à¢ds ›J™ÊY©¥hf‚g‚ašÙ±€yóm†!(ºsup„¡s¡¨˜In±ìl·Àa,席…¶ ree½â1/2…(subtot»9¸¸h€j§Ÿ®èctom”8o½ðw¿h—øau˜°XsƒHnµÏˆ‹fragmº2¾h do”h8»Á²®o›Àt´i¼Y¤hft-*¡‰¾=ce)½ËžJnew¬ðchniqu©–ùˆ9® nv¿ ¬¶ùo-–螉¹÷…ü§Ø ¬Ÿ7°¡š*im„ºH±ðopŸø•˜žÈ” _­ø™ ”øŒ’inc´Ø¾³8m® (¬¸¸ø³²˜¿žøŒ¹µp¿p¹°´Ý  ‚Ugam¯èpro™¨ºpd¦¹†Ê™onfiŠ8“²al…C§i ’sugg³òOH…L±h«@·PªxµØnƒ!¿(ºIˆD¸ÁRapž‰•ˆa·¯ym®»¨Žéž¢‡®£ƒòucc”P¿©¾‘ì»qDeep ’ap·(lˆH—É Ômanag»H½ù»ègµ¸pem«¼ü(70-8µ!ƒ\¿é‘*P©x¼_˜¾©cemiº¬X°°˜T€Ù¾w¨€”p«0¶i,µÈršØ²!®ùðhospŸ@“y•ÐìikéœÀ"Ÿwe·Ÿ=”Àay§Q˜â¦°%¸h ¼— Y¶Reƒ nQ[4%Ðr 10-2¼¸¸‘%ˆ²·Ÿ·Ÿ·šž¶ß]žšhung¸èb±Qsynd²p´è‡d‡Âˆ ‡o¹ ùdepo¾¹žÓŠyiumµ:ˆÆ‘²Ð´£áHoar¨è‹¤da° ‹òž¥t ¬Ðynge¾xner¹h(<1%¥ÑŽº¦sµø™ ¦‚Žu:•±”Œfail•É(2-8%)€Õ±inex¨ šøc¡Pun‹qgniz ¿¿ò©O©Hª@ernum—pг¿®À•µ¾œ˜¿2,÷•0h·²Èž9nyw°(µ ½Õ©Éµà¿Pib¶@¼€Šè½Hi¶‘§É¼ÁŠø‰©i—Ȫ†È8%¿¢eso”@‰©, 26%—€Š4‘a¿Q¾k)9%»˜rot¼¸she¿8À€˜‹ˆi»ø)¾ð‹—žü² ¾×™ :³èºp®ŠŠsµp·x³^tž·“³˜spec· ¬Ú(mil¯I»w‹×¸X (MENɯQ VI« Non-½i…Q Ä£‚ -Enc½À’‘amb¿³²©ºdequ”hyd¥q´h¿ v2hiaz¾¨s¸èMo¬p•¹diet9–­§Pak”Y›à00íg/d‰!L À€Ü±IagµHvƒ;‰¢5¿Ù›lossµÁTwiceù·ˆµ(™ü, ©X•,ª—ª“s.Ùsur¹€…”ðod÷òãlºXa¹(ƒ×´àˆžðt È -Or¾9¦%:±¹tr£¹´lŠys€xg¶(£Qª¼n¨àus¿ðw¡ «x¯sƒityándíayólightlyäecreaseãalciumìevelsJ€æurinaryèydroxyprolineåxàtion) Ináótudyïf 52ásymptomaticð€0entsîotõndergoingóurge‚Ø(10-yearæollowõp),ôhere÷a±ïverallãhangeénóer…ˆor…†$,ÐTH†L,bo…pm…˜‚‡nsity. No„½ˆ8‡°oped …¬s;èowˆ`r, 14/†x(27%)†Ù†^¯an„€dic‡Xon†r†Çin‹ ‚Ð……‹ž…J„ 5000ÉU/d): IˆÑu†’–—œø‰ùllálsoœx@„skin/de˜tit !pr˜Xtu pheadach‰Xromðseudotum‰ÁžPbri,’{xŒÐalopecƒ)hep”žðfun“ œøe”¹—twe™pt`s Mechan‡Øâsteoclas¤Ptim áÉ‘? am¤ÐˆŸEA”D—¤˜agœJ p‰Úy—hƒ(rm (†€¤è…ÙficŽZ¦—¦¥ñ‰Š¦Š©ž ‘h‚ ¥,„'Š@™Ðtives:¨`oœxa¤@(13-cis-€Œcácid)œ‘'(©À-¡©?;¥ºThiazideœhin—q„Ytub©ðr•iorp©µ™Ä)¢Òl¥š)carŸè«P (?al¤h°¨setð„øt˜w›x©¸”Ÿd«Z,¢€²@¬ºŠB¢yœý›†,«h„Ó‚'‚'°HssŸ-›h¨€Ð®apy–he¨0ž@±P8o’H°¡ªê¡îser p£©®Ð¯ØæaŸ(±8­Ç—2th±šßšÞ·nnot´qd£¬dõ”°®¸rugµñ®qdraw«¬·¶ì­A¦N§Ùa‘Ñhoh¤¸8º táf’á2-3íonth— ¸YŸ_„‡occ­Ø¨©~5%·th¨I·à‰-‰Ž±1o‚àŒèƒSsƒ\ »àstopp¬Ò‘w¼…unŒk°q®¹–HŸ½çi¾i Alu¹°ª’¢äª`ds« ˜Xªè´0iz¼ûdefectªè‘¸Ø–±(…:ž!bž#uppªPs­ê¹Èb»¸¥­ˆ–(•˜o®`­ircŸR¬ ”7qµx½xRµúµç¿8œÁŽAue„ê…Ǩ¤wh³¸€¾compoun†Phav¢´¡g8nãhron«@»qµppŒph™1bin¨¸µ ˆ¯« ©‚™l­ •ˆ£pžxád­ µºH¤`‘n¿È»ènutªÀ» Ÿ@‹4ˆÙ½i¸°®ñ‹(‚9hydrolys¹ˆsŸã’k-alk‹èóyn€øm¿€‚€ad:¯¯metabo„Я@ˆo”¨ñ¿!failure±N»8r–¢hН0adˆ€t¿ùnµhb¢ˆba·é†ô½YI§¿f £À«qu‡ð±Ð¤À¼ˆm…H¯‚„;i«H€á+óod¾¡b¶à¤Œ½½ia¨Yat±9¼êp¼X²0uµàr½»XT·±ˆ7c½!±P½ð Iµœ—8­a·neuµðus“¾Àr¶à”,·_,±èth†x€ ¹¹Š½oª{‹hŠïŠï¹azotš‰ ¬Õp ø·P­_’Ñ/Ca‹°¾˜š¿sž  »Ès–H­Â´0›(b¹Yk©ž°¬q)†qp•€¯¸`¹x(ºyŽ÷Žñœ#¾=»uch¢ëeM¼¼¨‰¶Éreg¾ ¶Ø×ªreliº¨·Š¯ú»‰«¹±MJ”³² ak° f½¸r±Pu—¡dam¼9hšÈ«Á§z³Àž’½!±‡¾c¶sžÇžÂ»€¶¶'¯Ð¿H£Ê¢ˆJ¿Èøažž ¹âPœ?œ?‡á¹Àulœ²¿±†8tooí‰Ñ¸½(> 300íg/daµˆ±h¢,åspeµ€«)´ÄºÀ”•¹[impair–Ù¾b8-chl…È-cycQAMP³éŒhšiµ0—™‰Ð¼ÈwhiðŠ¥ªf¦1©ü»S¼c1,25-OH-D¢ o½T®’IsoªÈ¿`Šù¾0«±Ð¨2s¨1¹ß·¼ò‹¬g¾˜iclovir,œˆs€net (²½?¾«™]¼!•Xre«¨ª(¨èçrowor¸ £r¿©¾1AIDS©0¢nt¥@manƒ¸¨¨¯ú´³Z²³‚ˆ©ahey™Âöac˜H´z‡k¥!mmo³1µ4 Pª`ºh¿Pi€×¬üweightlµƒ šhspa¨hfl€±)ŠQmžÐ•à˜øt±p´æb·p©¸,âu¥`rankºg’¾Ìon£y³àg‡>°É¿K‹zœ´Ðerly·ù·or³È¬A†ðel œ!‰Êurnov¿ (PšÀt's¸}‰Ñ…°‹hcy +/-ïvertókeletalí€0s€es,ðrimaryïróecond€ihyperparathyroidism,ópinècordénjuryñolonged†rest). Osteoclƒ áctivityésånhanc`andï!b'!diminish‚xdueôoìossïfçra‚0atio„biomec‚hic†peffect8nôhe‡4on. J„pRe…¹failure H†éÈcemiaïccas‚ºlyˆen†à†Hc‰™yðh‰0„ acute‡‚_e,…-rebou†˜„K…y‹@vatˆ°PTH‡rƒyitriol €ØelŠduˆYbyåarƒØ‹˜o„¬c ‹ðio‰ ƒÇ†e†È††may‹øïbservŒX†ˆI†/†-rhabdomyolysis-„%†³insufficiencyás…£umˆientˆðdeposi†¹‰muscleŽZsoftôiss 8mobilizedŒS’Ÿ’Ÿ’‹áurs‹‰chroŽp‹b(’ÿˆÿia•¨hosŒØŒ’t„è¸,álter”P‘I’@Ä—BbolƒY‹‚ingçl“ñ— •(rŒrsible)”Úincre˜ðú,Ž"˜ØƒP“ðótil˜)nt—ØlŽ‹À‰@‰„,âu—À—ØnyŠ&ªš‚>˜xhigher• anîormal™áTPiœ'œ'‰÷h•8—`”؆Nt‘¸†âs™©ŒHnhibi…š“ „æultˆI—8Ÿ:˜V(Ž8—ø„padenomaˆ•Xopbackgr—Bœ€Ša‰£extremeš —ç—à—js ˜C‰‹£'£'£'÷ithŸ w  et (av¤0íilk›°žP£Øcola)_e °ndŠ€(CaCO3¦– ac§°ð[P‘¸Lo]§cœ0amer; ‚ã—u9’ÉwhichÀ {“u¥‚‰bsorp¤i‘‹ž÷ (Rž1á,ß©jex) 0.25-1ícgÐOñ§ðr€ 5-3€šIV 3x/weekˆ HD¬q«ø¦ù¡¸‚¹Zem•xr‚Y‚B/kƶ«ÐIf†Ò§@®®­fr¬o¯€bonŠés†Ò¯è°¤’9¥j P«zᩨp®Ð  ±p°§« ¢X®Á¦`iŸŠªï’šusuªÊŠ ns¢Ðt)Ÿ¯õp¯30%¯p®è£8sá”0r«Tº8n¯Û«—³Ho´ðœ‰°ðª÷´‰ªÈ—½®¨o±Ø¤ø³™xli¿´€d-org›øµÈi¸ˆ´è³©­©dur¡qs”iinvoluƒm¸â „¢€¹7›Ð(6-12¨nths¸IA†b†7†4reg¹X³±¶á»¿»¿©'©$¾ 1-10ù±€‰0º¯Ä¥xoè¨H»Ø1-3%¼@qui¹¾t~3‚„׋»†áˆX¯ˆ ÷¹AºrK¾àHum‹Ðl¡çº3f´nign¿y A±¯describ¿°syndr½È¢¼&¸o¹‰-rpŽ<¹‚ËôƒÉ¢YFiv¼Qpor»½ðes:‰™xªH mžzys•x½ Ž8eæib³¡,¾àt‘Øi¾1lei¸Ym²xmammµ'°²³!eo´¹mocy—PaŽyƒr¢ymp€©«±ª7¼i•¨7†‹wºˆ…¦½aìœH›x´˜w«`n;½¢sour”(¿È¾羊b´±œ(¯ø¸èit¿Ê±Ó¼ð¶p½¸‹ˆžè(l¹‘) º Ѕ篷‹ãŒÈˆm»ðlupu²ð¿àat¦x¶@¿`˜‹Œ©¸/fŽ@µ n-µ¨ªtìˆh¶@€‘bL¶`JŸ¨en's¼Jphy£h¹Øh°0yžÉ¼™9utos³ˆläo½ÐŸx¾pž(²@½™muŸûˆº½È 1¼É/‘\“QŒ`r» ad¿¢ ±H¿$¶õ,²º´Ÿ¼`h’ìimb…‹**T¿°tm—Ù·¦O¸á—èT½hape @»Hoal“¨1.¶Àr—X™øehyd¤“; 2.Ån¾¸¢x¦Cex¿Å¥uum; 3.ɽ3µc¹À³É˜0¬Ñ½@³; 4.Ä£´!–´7¨'‚±5. †J’‚½xerly¿»or¹žRH…m:¥(’ex—™v‹ð¦ª¾‘™(bilit­èo»h¨à¾¼‘¨Ñ’ð ÿ¯Qcauœ@îep™˜g Xc½Ðab¤¨±sipidus”`esul¯(¯ð‰—nµÈŠD®Œ8ravascu· „¸»Èe¿ˆ‹Z˜cser½i¿”˜á¯¡š9d« ±R¾;Œ÷¯`a·¨œ t (1.5´.0íg/d™`¾qfac‡Á¶ˆ™´9ƒ=c“¶H±0²à«¸œ±1GFR³ ¸ €´@xi–‘sod…´w¹ ¶ÑÏ (†º8€Ì©Ypa°ð•8y¾Û‚#²‰Tail½hinfu±úŒÙli‹pƒQ½ðø(s—rÁ«G˜%ˆÄ»x•‡º°cardiª‹„³À“aƒ‚yp‚á¾2‰c4™½´ˆfÎSä„€yŸƒoop“ u¸¹cát¬¸¸ Ž exp¾x¾Bfuros²Àde¶5‘ø£b‹÷“J¸¹™÷™÷Œ™ê½AMŠï¿«8ª¡tk ’h¿€¾¡Ÿ™«l…±Ÿqen©) †7®Ñ–˜ŒÉŸ`o…ful¹gu‰x‡a–Àt”í½loa ˜ùgó¨È³Èad¦€º€‹Uespeci­‚°(elœò½@ti‰¶é¦HŽ e¼¦µÙšH·à‚¯¨µµ™x (80¾10–yÉV Iy 1-2èours)÷ithæluidándålectrolyteòeplacementâasedïnõrinaryìossesésìaboréntensive (‚Aof€xãomplicatàbyèypokalemia,€jmagn‚È€€)âutåffƒø‚(. Dialysis: Inôheóetting‚ð„ènalæailure,áttemptsôo„Xcre…€$calciumåx€¸ti† are… inƒž,†÷hichèperitoneƒ0†øhemod„„ (€wˆmo‚x…ÖŠ”a‰wƒÞÓˆ8íayâe‰pdˆ»‡JBispho€!n‰X‡€C‰ÀoundsŒ l‰ò†¸pyro;Š€,‰‚reˆøta€äPs€øƒˆihydroxyapatiŽ ‡ b†¨binhibitãry‚(l…0ssolu‰. HaŽ`veZ‹˜halfìif‚I‚ osteoclasŒ’)ca‹ lsoäeŒTöiabilityƒ SerŒÈ beginŽÆ‘¨24-48•s,”˜ach“¹Pnadir–È7äay‡¸–!‹!ƒZf”Àweeks†xD„\d–ˆÔp—p8…Ì‘[ref˜A†•ð‰©‹xorp‰Poorlyáb€ b˜árally;”ˀȓ{Íu‡¸¨wellŒ‚˜ƒe„øeõ•@Œkf€Ydrug”Ilarg‹øŒxm•abeca‰precipitšÊ‰þ’7“QœÐnephrotoxic (™‹‹ufficiencyña“Écontra”Ü™@)œ0-Eti’‚’(D€Zel)Ÿ¹gŸ`šXt 7.5íg/kg/ŒÛo‘  4¢û]ø 3-5Œâ.Ád’xœ¸Ÿ3¡ànclude ƒ¨¡Ð£1Հᔸe• nŒå™ruŽqUnlikž( ¨r‡Ï™û, Ÿ0…¥…3–-ter“a¤°Š"•ªma§ia‡IPam‡WAreŸp‡Bžÿ¡330-90‡ˆÉV¬¨À‡¢-2‡¸r.¢JŸð¢¥Xs—umš¸M ˜â 0Š‘Ë (1.2çñ‚t‰«¨»—«Sess’3tole’:HŠ¿Š»¨è„Øadm‰àsŽˆ§š‹eaíild,‹§©w§øª!‚ÁªšŒ¿leukopen­¹Žùshoot®rªá®y±âaóŠ€l±Àdu®0ƒ²ˆ¥Æ’™Alen’¦Fosamax)¨Õ”(sideŒá†`š¨¯Ñrapyžz…ñ²AerƒÝ¨S¦8—‰„¸apžvµhŸñ‰Ó–––‰NewЉrdçenŠ)°‘™ç¬ (ib¸p—ã°i·è˜,[Ac°±l],úŒ(˜ä)©·Øbe·¨f­Ñ´A¯@°âpo¸ØŽ1¨¸p“7·’º…¹ye¥Òhe¦Á±Hº oòo¬­c¥0ºXl¡‘¸úPºÑmycµ¸(M¾0r€k):Á¶É®â¼È¹`DNA-deŽd¾YRNAóynº€¶a·“°\‘è­OfunŽ3¾‰g°ØGŸÚ“)t 25 (Ÿé˜%6­]°Lº¸f¤Hede“°·Ðr„@¶’¡Ð‡erv±P¾‰¯G­yC°§°§¾³¸ea«Ús 12°Óá¾xrª+¿°ExiŸ”‡ïcci¿H48-7ä,¿YºAy±™se·¸¸²»É²¦¦(do­‘ŠÍ¨°¦Œn­)™`he»°¬·€ (§J£8nit”º 20%®é¼á§øs),­Ÿš„Ø®einµ ›#8ombocytœ‹½HEx­°vasŸK± ¹rr°ùýc³Øu»¨i¸XC¯?¯:»’´:´x­ñžØ…ɱ¨º±»dys}¡à„' ª9coagulo‡€hy”òŽ ™Pin:¥Œòa 1Õók£Jst,óalm¤à(™7™4human)¼{‚"³SC„±IM³U“¹ayG(¯ g†€pœ8'y ”Ô)½àLªIœ¼comp‡Ð“º :£ˆp›7¬Ym±¸ ¤p¼h¥H ¼àa§k†8¿@´Á¿ðdu¶Ào¥WiŽcT);½¦star¸P¡hf©Ñ¿Èa楚$wž¸’pd €¸Àch¿p€™¸è12³r›[±!o˜n¾`b£ñs™pspi½ ¾¡‘øªq°°‰… d—`¸m»ñ±Èr ¡tance»(S½¼ð³éa©`t'›È½Ú¿ùweak¼Â°hrt-l»@dµjˆê,®F¬Ñ­É»™¾¨rhighˆl„‹Zwh½Xvigo§˜s²ødµå®Ëpossibl¿°ŸIÁbi¿ˆ¶ñ±¡Å‘žsafe;¸X¹¹ ?;abdo¹h³Pcª p¥àflus‹0gàl»Hg˜XŒ™s™9unusualƒ•!hµˆ¯da™¨g«cž º˜Ÿ¨˜­Ðful‡C¶¨ŸÅËœ€ébonyíet¬¼¨sšc‹ic¬Ùroids:Çlucoc€³€ˆ»ðtag›`zy¥¯Øv 0£ˆÄ•x“¶absorp½„Qg¯ˆ‚଀¨9»¡r–°®+²\å£A {1a-Œùoxylº(th˜¨Ë°è½Zg§p ˜m¨Žxdº †‰,ìym»`m½È„ï·Q©0½*)ƒ·´‘grow˜0¶8neop´Ñ¤È‚#œ(ªHs›X„„¸ multip‘xmy—ƒyƒÍ Also†Ös²Ù± ¬h½riœx¼mp–èŠðŒdi®`³Pby†¬ «H(IFN-g,ÉL-1€30£M½ø¶Èo’´ÉªŽÉbolismŒïŒé  v£yroµnf¾0¢áЀũÀ¶å„ðŒÌ½§¤\½½‚†!™ÙŒÏ·nonhematologicôumorsïrðrimaryèyperparathyroidism. Doseés 40-100ígÐOñdïfÈednisone‚92€óto 3CIV)hydrocortKÐfƒ 3-5äaysƒShouldîotâeõsed„‘„À‚Pobtainingádequate ‚@sueóampl€Éifíalignancyóuspect‚ („¹d…éwillálterèistop‡ˆ)y,é.e.ìymphoma)‡pHypocalcem‰respon‡ûvariable (may…Irapiˆ0…8ake 7ˆè†Š). GalliumîitŠxe: Inhibitsâ‰y‚Ðorptionây†à€pb‡1‰èandƒÈduc€‚h‡PolubilityŠ~xya†(iˆpcrystals (noäir‡àåff€9‚àosteoclast„À Givenásáãontinuousénfus„Q(Ž/m2€  1 ƒ˜‰˜qd)’fèŽÐ¶‡ù‚bout 3Ž¢reach…úŠqˆYlowerŽQ„ýf€ÛtoŒø’0,â‚(‡ nåxceed„ètóŽàificantly (up“’0ld),óer‹@ƒ-ƒº„xnaˆ`„}afÙ‡=–˜U–“limŠdŒnephrotoxi„ˆƒ(mŽ¡sure ‹Aent˜we’@–y”8ƒÙ™€o‘Èsph”Àmia,äec‡È–˜Ðâloodã±massÊChloroqui™ QŽ|c€¿‰ˆn ‰ät˜h–¸Š]èc„ H’Ž ˜prcosiš‘Possib‰hPZømedi…Á“i”c“ñž0macr†@ageÉL-1 xo“ð€ór”ú„|”Á˜Š’9esBstimul¢¨¢cytok†È‡SKetŸ¸nazo™¨’€highœƒ‡ „ ŒochondšðlÐ450-ž°k  1a-—d–™‘gardlƒ¹£Ðwhe˜ØŽ¨ŒÊrenè¦Pex›x€s—0ˆÇˆÁZubercul‰BAMošÑzŠJ:Émm€‡˜€@ƒse…à¤ñ  ng)ácލežÉŠÀ‚Šrsk€Øœ—Å•ž mb‰)Ÿys§s§Pencour‹¸d¦!p£e¡úIndom‡a (:½t 25«ùq 6è­Áaspiš ‡Ÿ¤ªñ®äŽS©ñŽ ¡8gl¢èi‘(‰1¥SP– ‡øV£`d¥¹–¶”k§Q›Øž†ÇawithçŸhtòisk°¬cipitŠ#¢H˜;v‘ˆels,ìung€8kidne¡`whi¡H—¡lead’ševe›Èorg˜Hdam”ɤaб›¡te”žJL”1‡ß*’8œ®,ç‰å0.5çâ­˜µ1.0€ht®(in°ÀfƒˆŸ†iab¬Ö·diŽ`–ÙŽm™Ü®?®<€×”tßšn³M¶€µˆ‰ƒ¸Y•ó´Àš ¼yÈ­ˆ®øc©ã§ÙŠcf¹(râ—Šfun;±™€Ô(¾€«P)¨Ä¤ûoru»IBest»êc§`n·šapy.Óid’¿Y¡Prrheaº ŒX 2‰È°0¸óer§ŸiaµrŸ€l©€²Ér½ d…´§»An“ð¯H´H¶)PTH·B¶ùºÉ´9h•¡†±ac¢pµ «èbe¿Ùsyn¸@siz¾°²†@™©¢ op‰¡@‘ loprp”±x†÷ômi𾍧@n¼8(“Ëal·!»9Šv»(»¹¢b­é¦ø—¶-s“á½H»Hep§° h±(¹x„m±`»PR-568,»A´Îƒƒøˆ:,¸Àu±I¨’depend³:¬ß‰Ds²¡>º2µ º¶‡É¾ˆt«½x«°špr“8¬°µ0 aµ¨hyr± ism¾Al¤¸Šû‰äŠé·€ˆü¾‰ˆ”vžPm½D'³I±Ç„ìŒÜ»(¶h¦%³³ grow¡8 á„?›ðssu§{ **Reœ)¶À¤ðv1.2.8)€ÉBas²˜ÈJ¶¹†—†—†“:¾wïÂs¨½èg™È»Ùn¶ØŒÄEªÈcr‚P“( 2001;7:313-317¼øBileziki¼JPYÞ¹Aacu¨ˆŠz¼Á¿‘»`N‚ glÊ͵¡992;326:1196-1202‚±odyʆ C¶Ø„¢º@²`§Àupd«Ú¹)·`n½•‚¿r‚q7;80:1699-1701…uch®kyÄA,ÍonkÒD—uŽÑLét„Y8;352:306†øáCh»ÈFK,Ëo¸8¼°LM,Ôhys-JacobsÓ, ˆˆDi²È»t¼ù Àgnºa•ô®p£Ù‹¼Ù‰‰ Cur‹‰obÓŒ˜†«34:444-523„¹›keÂL£ Š÷ÍTPȵ¨out±Ø82§HAnnu¿pMežp¶ÐtŽËi¬ Soc­¨y,Êu­21-24,Y0:58-6Š!Do‹py ‡èBalf¼ ÊA²hIb¸ðŒ&Drugsމ9;57:101-108¼èLe·Æ,ÇrillÖ,ÈoÐWŠPMar„Ô•Y†G©)œregnޏyž3§ ¹ass…€»ødºcOd¦ðrm³0-rel ¾xt¨ˆ“¯“®3“¨8:666¾˜„8xÓ„.Ÿ×©ëº  w¤i·€der± NEJM‰Z3:1863-1875®Nussba²ˆSR‡Ðaz“¨,ÁrnolŒˆÇ‡„´¼˜¬€c¥ÿ †÷º!bˆ™ï°9¿€c˜¸inoma¼sr™8ranœ/±‘®­x¹Ð²8œœ…ð2…ð324-‰Ravakhah —ÈG¶‚™ÉukundaÂN¶±³Ôžß¶ÒŒ×ŒÒa Ÿø“fibªIª1nnÉ­°Ÿä9;130:7Ÿ²Rau‘8’¹n®a¯Yinc»@§¸‡Hdi‡°sc³¬¸)­×­×­×sm -²¢±Ð¾J¹­‘g¢€siveô‰€t´?§X–Á£š…v ‚;28:277-278. SakyÍT,ÈasinskiÓ,ÒoseÌI. Ectopicðrimaryèyperparathyroidism1ndocrÐract 2001;7ƒ2ƒ4ƒeymourÊF,ÇagelÒF‚ØCalcitriol:Ôheíajorèumoralíediat€ˆofƒ«cxemiaénÈodgkin's „ea…handîon-€×lymphomas†0Blood 82;1383-139„ºilverbergÓJ‡Ydiƒ€ia„xcardiovascularƒ.ƒÐˆGˆGˆGJÃl„øˆ{inolÍetab€@ˆ¨0;85:3513-ƒ÷ƒô,ÓhaneÅ,ÊacobsÔP€ iris€¡BilezikianÊPŒ¨A 10-ye„Ðprospectiveótudy‰yggd÷ith ‹8€Aout Ž_dóurgery°NŽgl†xMed 1999;341:1249-55‘¨ ‰†Èƒ¸review …Paóynthes…°°€P‚ø‘xŒ`ist‚PЀ©referencesó…áon“IŒ`yåffortèasâeen deôoån„è0ccu“ y,â…àI‘˜ke¸÷arranty„hgÙngårroƒÐÁomissƒ0€sassum²resp€°ibilià“èlia€l„8ìos†Høam•°yult‚áfrom†úin…xma†ãontain‰ˆ‹!i† Fáð‡á_ˆ+†ØróŒ0ldˆ›‡I‰©”(gin˜ textŠU‰¯.Õœð‹ Œ#„Gn…Òp„˜ent–AŒ urpž€sdo“0atŒâàcre…âtc•èic“8PlšÒem†œx‘Ûany‡Pmm‚ðˆâsuggesŽ!s¢hMarkÇ›`arzi,Í.D£mg€Œ@ž net.ucla.edu ’@<**>